Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells.
暂无分享，去创建一个
P. Atadja | R. Levine | K. Bhalla | R. Balusu | C. Ustun | W. Fiskus | K. Buckley | Rekha Rao | Daniel G Chong | Atul D Joshi | Jianguang Chen | A. Jillella | Yongchao Wang | S. Koul | A. Savoie | Kavita Natarajan | R. Levine